Penobscot Wealth Management Johnson & Johnson Transaction History

Penobscot Wealth Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$155.22 - $162.74 $196,198 - $205,703	1,264 New	1,264 $200,000
Q3 2023 Oct 25, 2023	BUY	$155.75 - $174.48 $246,863 - $276,550	1,585 New	1,585 $247,000
Q4 2022 Feb 02, 2023	SELL	$160.2 - $179.79 $12,816 - $14,383	-80 Reduced 6.52%	1,147 $203,000
Q3 2022 Nov 15, 2022	BUY	$161.33 - $179.52 $483 - $538	3 Added 0.25%	1,227 $200,000
Q2 2022 Aug 04, 2022	BUY	$168.19 - $186.01 $6,391 - $7,068	38 Added 3.2%	1,224 $217,000
Q1 2022 May 19, 2022	BUY	$158.14 - $179.59 $474 - $538	3 Added 0.25%	1,186 $210,000
Q4 2021 Jan 24, 2022	SELL	$155.93 - $173.01 $36,019 - $39,965	-231 Reduced 16.34%	1,183 $202,000
Q3 2021 Oct 04, 2021	BUY	$161.5 - $179.47 $484 - $538	3 Added 0.21%	1,414 $228,000
Q2 2021 Aug 05, 2021	BUY	$159.48 - $171.07 $225,026 - $241,379	1,411 New	1,411 $232,000

4,227

1.7B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $410B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Penobscot Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Penobscot Wealth Management with notifications on news.